Gene Cell Nano
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
News
- 1.4M€ Novo Nordisk Excellence Emerging Investigator Grant awarded to GeneCellNano Flagship PI Anna-Kaisa Ruotsalainen
- Professor Seppo Vainio’s group in new Business Finland Leading Company ecosystem
- The GeneCellNano 5th Annual Meeting 23.-24.4.2026
- A new method improves nanoscale particle separation and purification
- Professor Seppo Ylä-Herttuala invited to the Polish Academy of Arts and Sciences
GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.
